Search

Liver Disease Treatment Market

Liver Disease Treatment Market Size by Disease Type (Genetic Disorders, Cancer, Hepatitis, Non-Alcoholic Fatty Liver Disease (NAFLD), Autoimmune Diseases, And Others), Treatment Type (Vaccines, Immunoglobulins, Targeted Therapy, Antiviral Drugs, Chemotherapy, Corticosteroids, And Immunosuppressants), End User, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-13039
  • Published Date: Nov, 2022
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global liver disease treatment market is expected to reach USD 27.45 billion by 2030, at a CAGR of 6.42% from 2022 to 2030. The growth of liver disease treatment would be driven by the increasing incidence of hepatitis, cancer, autoimmune diseases, and non-alcoholic fatty liver diseases. The growing geriatric population significantly contributes to the rising number of liver disease patients, given that their immunity starts waning with age. The rise in government healthcare expenditure to make treatments accessible and affordable for the citizenry will also aid in the growth of the liver disease treatment market.

Market Overview:

The liver is an integral part of the human body. It is located on the right side of the abdominal cavity. The liver is dark reddish brown. It is shaped like a cone and weighs around 3 pounds. The liver performs various critical functions in the body. Some primary functions it carries out in the body are bile production and clearing the blood of drugs and other poisonous substances. The bile secreted by the liver helps the body break down fats in the small intestine during digestion. The liver clarifies the blood and removes the toxins from the human body. Producing proteins, and cholesterol, converting excess glucose to glycogen, poisonous ammonia to urea, and regulating blood clotting are other functions performed by the liver. Liver diseases can be defined as conditions in which the liver is damaged or unable to function well. Liver diseases include non-alcoholic fatty liver disease, hepatitis A, B & C, cirrhosis, hemochromatosis, and liver cancer. Liver diseases are caused due to excessive alcohol use, obesity, exposure to other people's bodily fluids, unprotected sex, or it can be genetic. The liver disease patient experiences fatigue, abdominal pain, swelling of the legs, itchy skin, nausea, and yellow eyes. Proper medication and avoiding alcohol or liver transplant in advance cases are some treatment options available for liver diseases. With scientific breakthroughs, vaccines are now available for hepatitis. Similarly, antiviral drugs to prevent infection are saving lives globally.

Liver Disease Treatment Market Size

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:

  • Increase in incidence of liver diseases

An increase in hours spent in Infront of laptops and mobile screens combined with a sedentary lifestyle, no physical exercise & unhealthy diet has led to an increase in the number of individuals suffering from liver diseases. The growing geriatric population has witnessed an increasing prevalence of liver diseases like hepatitis, non-alcoholic fatty liver, and other autoimmune diseases. Increasing alcohol consumption has also contributed significantly to the growing number of patients. Various treatments are deployed to treat the ever-increasing number of patients suffering from liver-related diseases caused by unhealthy lifestyles, unhealthy diets, heavy alcohol consumption, or old age, which will drive the global liver disease treatment market.

Restraints:

  • Liver disease treatment drugs or/and therapies are expensive

Extensive capital is utilized in the research and development of drugs and therapies used to treat liver diseases and associated conditions. Market players use the latest technologies and innovations to improve the efficacy and safety of these drugs; such technologies are expensive, making drug development a costly affair. The complex regulatory approvals and numerous trials to test the drug further add to the costs. The high costs of liver disease treatments will hamper the market's growth.

Opportunities:

  • Increased research and development

With the increased demand for liver disease treatments, major players have invested capital in researching and developing better drugs, devices, and treatment options. For example, in December 2020, the American biopharmaceutical corporation Gilead Sciences, Inc. announced the acquisition of MYR GmbH, a German healthcare organization focused on discovering and commercializing therapies for treating chronic liver disease. Gilead declared its intention to buy MYR for approximately USD 1.36 billion in cash. Other such developments and advancements in the liver disease treatment market will make the industry competitive and help it become more efficient, providing the necessary impetus to its growth and lucrative opportunities for the market players.

Challenges:

  • Stringent government regulations and guidelines

The innovations in liver disease treatments in the form of new drugs or therapies need to be tested thoroughly via different methods before being employed in treating patients commercially. Successful trials are followed by proper approval from relevant authorities. These authorities maintain high compliance and accountability standards as they need to safeguard the target audience's interests and save them from any ill effects of the drug or therapy. The scrutiny that the market players have to go through is time-consuming. The timely launch of products and benefits associated with it are affected due to these regulations, leading to a drop in profits.

Segmentation Analysis:

The global liver disease treatment market has been segmented based on disease type, treatment type, end-user, and region.

  • The disease type segment is divided into genetic disorders, cancer, hepatitis, non-alcoholic fatty liver disease (NAFLD), autoimmune diseases, and others. The hepatitis segment dominated the market with a market share of around 37% in 2021. The inflammation of the liver is a result of hepatitis. Hepatitis can be classified into A, B, and C according to its different properties. The increasing consumption of alcohol, unmedicated drugs, and medical errors are the primary causes of the increase in the number of hepatitis patients. Hepatitis is prevalent in low- and middle-income countries, given the lack of access to clean water and food. Decade-long research has led to the development of vaccines for hepatitis. The previously mentioned factors contribute to the dominance of the hepatitis segment in the liver disease treatment market.
  • The treatment type segment is divided into vaccines, immunoglobulins, targeted therapy, antiviral drugs, chemotherapy, corticosteroids, and immunosuppressants. Over the forecast period, the antiviral drugs segment is expected to grow at the fastest CAGR of 9.50%. The rising awareness about antiviral drugs and their related benefits will contribute to its growth during the forecast period. The increasing government initiatives to make healthcare accessible and affordable for every citizen will also aid in developing the segment. The growing socio-welfare programs spearheaded by international organizations to provide affordable healthcare to the remote population of the globe will give an impetus to the segment during the forecast period. The growing research and development by market players for more effective and safe drugs will also contribute to the development of the market.
  • The end-user segment is divided into hospitals, clinics, diagnostic laboratories, & others. In 2021, the hospital segment dominated the market, accounting for around 47% of global revenue. With the pandemic exposing the poor state of healthcare infrastructure, governments worldwide are focused on increasing capital spending to boost healthcare infrastructure and its holistic development. Increased investments will help develop the infrastructure for better systems to disburse treatments, keeping the hospitals' segment dominating the global liver disease treatment market.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the largest market for the global liver disease treatment market, with a 37.6% share of the market revenue in 2021.

  • North America currently dominates the liver disease treatment market due to the increasing number of liver disease patients caused by excessive alcohol consumption, unhealthy diet, and sedentary lifestyle. The government's renewed focus on providing the necessary treatments to patients at an affordable rate is also expanding the market for liver disease treatment. Significant market players in the region contribute to its growing dominance in the liver disease treatment market. At the same time, Asia-Pacific is expected to rise in the forecast period due to increased government expenditure on healthcare infrastructure and the rising geriatric population.

North America Region Liver Disease Treatment Market Share in 2021 - 37.6%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global liver disease treatment industry.

In partnership with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, Saint Louis University's School of Medicine scientists have developed the first efficient medication to treat a rare genetic liver illness previously only curable through liver transplantation. They successfully tested the efficacy and safety of fazirsiran, an RNA interference medication, in people between 18 and 75 with a liver disease linked to alpha-1 antitrypsin (AAT) deficiency.

List of Key Market Players:

  • Johnson & Johnson Services Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Abbott Laboratories
  • Novartis AG
  • Eli Lilly and Company
  • Gilead Sciences
  • Bristol Myers Squibb
  • AbbVie Inc.
  • Zydus Pharmaceuticals Inc.

Key Target Audience

  • Hospitals/Healthcare Providers
  • Market Players
  • Investors
  • End-users
  • Government Authorities
  • Consulting And Research Firm
  • Venture capitalists
  • Third-party knowledge providers

Report Description:

  • Global Liver Disease Treatment Market, Industry Analysis, Trends, Analysis and Forecast, 2022 to 2030 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2021 is considered as the base year of the report. 2019 and 2020 are considered as the historic years and 2022 to 2030 are the forecast years. The global liver disease treatment market is based on revenue (USD Billion). The report incorporates the market study based on revenue. The study covers the market share revenue/market share/volume for each of the segments, regions, and countries catering to the global liver disease treatment market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts across the globe. The research report also delivers an outline of the attractiveness of liver disease treatment based on disease type, treatment type, end-user and regions which are deduced and formulated based on their growth rate (CAGR), market size, and attractiveness by analyzing the present and prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to the global liver disease treatment market. This offers vital and in-depth insights to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global liver disease treatment market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario.
  • The report provides an elaborative assessment of the porter's five forces analysis coupled with SWOT analysis to provide business related data and information. Porter's five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company's growth and development to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors.
  • Potential growth prospects along with the penetration rate analysis of the product (market related, i.e., global liver disease treatment market) are covered to comprehend the adoption rate and evaluate the market size. 

Frequesntly Asked Questions

As per The Brainy Insights, the size of the liver disease treatment market was valued at USD 15.68 billion in 2021 to USD 27.45 billion by 2030.

Global liver disease treatment market is growing at a CAGR of 6.42% during the forecast period 2022-2030.

The market's growth will be influenced by the increase in incidence of liver diseases.

Liver disease treatment drugs or/and therapies are expensive which could hamper the market growth.

Increased research and development in liver disease treatments will provide huge opportunities to the market.

Key players are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Gilead Sciences, Bristol Myers Squibb, AbbVie Inc., and Zydus Pharmaceuticals Inc.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Disease Type
          4.3.2. Market Attractiveness Analysis by Treatment Type
          4.3.3. Market Attractiveness Analysis by End User
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increase in incidence of liver diseases
    5.3. Restraints
          5.3.1. Liver disease treatment drugs and/or therapies are expensive
    5.4. Opportunities
          5.4.1. Increased research and development
    5.5. Challenges
          5.5.1. Stringent government regulations and guidelines

6. Global Liver Disease Treatment Market Analysis and Forecast, By Disease Type
    6.1. Segment Overview
    6.2. Genetic Disorders
    6.3. Cancer
    6.4. Hepatitis
    6.5. Non-Alcoholic Fatty Liver Disease (NAFLD)
    6.6. Autoimmune Diseases
    6.7. Others

7. Global Liver Disease Treatment Market Analysis and Forecast, By Treatment Type
    7.1. Segment Overview
    7.2. Vaccines
    7.3. Immunoglobulins
    7.4. Targeted Therapy
    7.5. Antiviral Drugs
    7.6. Chemotherapy
    7.7. Corticosteroids
    7.8. Immunosuppressants

8. Global Liver Disease Treatment Market Analysis and Forecast, By End User
    8.1. Segment Overview
    8.2. Hospitals
    8.3. Clinics
    8.4. Diagnostic Laboratories
    8.5. Others

9. Global Liver Disease Treatment Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Liver Disease Treatment Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Liver Disease Treatment Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Johnson & Johnson Services Inc.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. F. Hoffman-La Roche Ltd.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Pfizer Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Abbott Laboratories
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Novartis AG
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Eli Lilly and Company
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Gilead Sciences
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Bristol Myers Squibb
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. AbbVie Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Zydus Pharmaceuticals Inc.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1. Global Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

2. Global Genetic Disorders Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

3. Global Cancer Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

4. Global Hepatitis Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

5. Global Non-Alcoholic Fatty Liver Disease (NAFLD) Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

6. Global Autoimmune Diseases Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

7. Global Others Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

8. Global Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

9. Global Vaccines Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

10. Global Immunoglobulins Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

11. Global Targeted Therapy Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

12. Global Antiviral Drugs Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

13. Global Chemotherapy Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

14. Global Corticosteroids Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

15. Global Immunosuppressants Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

16. Global Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

17. Global Hospitals Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

18. Global Clinics Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

19. Global Diagnostic Laboratories Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

20. Global Others Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

21. Global Liver Disease Treatment Market, By Region, 2019-2030 (USD Billion) 

22. North America Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

23. North America Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

24. North America Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

25. U.S. Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

26. U.S. Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

27. U.S. Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

28. Canada Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

29. Canada Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

30. Canada Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

31. Mexico Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

32. Mexico Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

33. Mexico Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

34. Europe Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

35. Europe Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

36. Europe Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

37. Germany Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

38. Germany Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

39. Germany Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

40. France Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

41. France Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

42. France Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

43. U.K. Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

44. U.K. Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

45. U.K. Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

46. Italy Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

47. Italy Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

48. Italy Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

49. Spain Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

50. Spain Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

51. Spain Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

52. Asia Pacific Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

53. Asia Pacific Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

54. Asia Pacific Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

55. Japan Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

56. Japan Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

57. Japan Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

58. China Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

59. China Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

60. China Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

61. India Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

62. India Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

63. India Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

64. South America Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

65. South America Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

66. South America Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

67. Brazil Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

68. Brazil Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

69. Brazil Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

70. Middle East and Africa Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

71. Middle East and Africa Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

72. Middle East and Africa Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

73. UAE Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

74. UAE Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

75. UAE Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

76. South Africa Liver Disease Treatment Market, By Disease Type, 2019-2030 (USD Billion) 

77. South Africa Liver Disease Treatment Market, By Treatment Type, 2019-2030 (USD Billion) 

78. South Africa Liver Disease Treatment Market, By End User, 2019-2030 (USD Billion) 

List of Figures 

1. Global Liver Disease Treatment Market Segmentation

2. Liver Disease Treatment Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Liver Disease Treatment Market Attractiveness Analysis by Disease Type

9. Global Liver Disease Treatment Market Attractiveness Analysis by Treatment Type

10. Global Liver Disease Treatment Market Attractiveness Analysis by End User

11. Global Liver Disease Treatment Market Attractiveness Analysis by Region

12. Global Liver Disease Treatment Market: Dynamics

13. Global Liver Disease Treatment Market Share by Disease Type (2022 & 2030)

14. Global Liver Disease Treatment Market Share by Treatment Type (2022 & 2030)

15. Global Liver Disease Treatment Market Share by End User (2022 & 2030)

16. Global Liver Disease Treatment Market Share by Regions (2022 & 2030)

17. Global Liver Disease Treatment Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global liver disease treatment market based on below mentioned segments:

Global Liver Disease Treatment Market by Disease Type:

  • Genetic Disorders
  • Cancer
  • Hepatitis
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Autoimmune Diseases
  • Others

Global Liver Disease Treatment Market by Treatment Type:

  • Vaccines
  • Immunoglobulins
  • Targeted Therapy
  • Antiviral Drugs
  • Chemotherapy
  • Corticosteroids
  • Immunosuppressants

Global Liver Disease Treatment Market by End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

Global Liver Disease Treatment Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date